By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Shire Pharmaceuticals Group plc 

Hampshire International Business Park
Basingstoke  Hampshire  RG24 8EP  United Kingdom
Phone: 44-1256-894-000 Fax: 44-1256-894-708



Company News
Shire (SHPG) Delivers Record Full-Year Revenue And Strong Double Digit Growth In Non GAAP Diluted Earnings Per ADS 2/11/2016 9:22:41 AM
Shire (SHPG) Partner, Shionogi, Submits New Drug Application In Japan For ADHD Treatment For Children 2/11/2016 6:37:10 AM
Shire (SHPG) Marks 30th Anniversary With Innovative Global Program To Benefit Children With Rare Diseases 2/9/2016 11:23:55 AM
ACMG Foundation Receives Major Gift From Shire (SHPG) To Support Training Of Next Generation Of Medical Geneticists: $1.65 Million Grant Will Fund 10 Training Fellowships 2/9/2016 7:21:14 AM
FDA Acknowledges Receipt Of Resubmission Of Shire (SHPG)'s New Drug Application For Lifitegrast For Dry Eye Disease In Adults 2/5/2016 6:14:40 AM
Shire (SHPG) Assigned Investment Grade Credit Ratings By Moody's And S&P 1/28/2016 10:49:56 AM
Shire (SHPG) Remains Tight-Lipped on Status of Facilities, Employees Inherited from Newly-Acquired Dyax (DYAX) 1/26/2016 6:51:31 AM
Shire (SHPG) Resubmits New Drug Application For Lifitegrast To U.S. FDA 1/25/2016 6:05:10 AM
Shire (SHPG) Completes Acquisition Of Dyax (DYAX) 1/22/2016 8:03:56 AM
Lucerne Biosciences Completes Sourcing Investigation Into Shire (SHPG)'s IPR That Led To The Invalidation Of The '813 Patent 1/15/2016 6:17:44 AM